Inventor · disambiguated record
Marina Konorty
Also filed as: KONORTY MARINA
8 granted patents·10 pending applications·54 citations·filing 2012–2023
86Inventor score
Top patents by PatentIndex Score
18 records- 0191US10471150B2Material and method for treating internal cavitiesUROGEN PHARMA LTD·Filed 2013·Granted Nov 12, 2019·9 cites·13 claims
- 0289US9950069B2Material and method for treating internal cavitiesUROGEN PHARMA LTD·Filed 2016·Granted Apr 24, 2018·10 cites·30 claims
- 0389US9040074B2Material and method for treating internal cavitiesHOLZER ASHER·Filed 2012·Granted May 26, 2015·17 cites·22 claims
- 0487US10039832B2Material and method for treating internal cavitiesUROGEN PHARMA LTD·Filed 2015·Granted Aug 7, 2018·7 cites·23 claims
- 0587US9801854B1Slow release formulations of cell cycle regulators and anti-cancer agents for local treatment of solid cancerTHERACOAT LTD·Filed 2015·Granted Oct 31, 2017·8 cites·14 claims
- 0686US10758482B2Immunomodulating treatments of body cavitiesUROGEN PHARMA LTD·Filed 2019·Granted Sep 1, 2020·3 cites·15 claims
- 0782US2023241220A1Material and method for treating internal cavitiesUROGEN PHARMA LTD·Filed 2023·Application pending·0 cites
- 0882US2023241221A1Material and method for treating internal cavitiesUROGEN PHARMA LTD·Filed 2023·Application pending·0 cites
- 0982US2023233685A1Material and method for treating internal cavitiesUROGEN PHARMA LTD·Filed 2023·Application pending·0 cites
- 1078US2022118096A1Material and method for treating internal cavitiesUROGEN PHARMA LTD·Filed 2021·Application pending·0 cites
- 1174US2020114008A1Material and method for treating internal cavitiesUROGEN PHARMA LTD·Filed 2019·Application pending·0 cites
- 1271US12171747B2Material and method for treating cancerUROGEN PHARMA LTD·Filed 2023·Granted Dec 24, 2024·0 cites·9 claims
- 1371US2023218521A1Immunomodulating treatments of body cavitiesUROGEN PHARMA LTD·Filed 2023·Application pending·0 cites
- 1464US12336979B2Material and method for treating cancerUROGEN PHARMA LTD·Filed 2021·Granted Jun 24, 2025·0 cites·6 claims
- 1562US2024100019A1Compositions comprising a thermoreversible hydrogel, and having an extended in-use periodUROGEN PHARMA LTD·Filed 2023·Application pending·0 cites
- 1661US2020397695A1Immunomodulating treatments of body cavitiesUROGEN PHARMA LTD·Filed 2020·Application pending·0 cites
- 1753US2014142191A1Production of thermoreversible hydrogels for therapeutic applicationsDE LA ZERDA JAIME·Filed 2012·Application pending·0 cites
- 1852US2017143833A1Production of thermoreversible hydrogels for therapeutic applicationsUROGEN PHARMA LTD·Filed 2017·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →